A Study of Oral Recombinant Salmon Calcitonin (rsCT) to Prevent Postmenopausal Osteoporosis

NCT01292187 · clinicaltrials.gov ↗
PHASE2
Phase
COMPLETED
Status
129
Enrollment
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

Tarsa Therapeutics, Inc.